ArticleTherapeutic advances in gastroenterology2025

Efficacy and safety of dual-targeted therapy for inflammatory bowel disease: a retrospective multicenter study in China.

Xiuxiu Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.